For the second quarter of 2023, Alphatec Holdings, Inc. (ATEC) dramatically reclaimed the position of #1 market share gainer in the spine industry by reporting a stunning 32% increase in procedure volume with a 7% increase in revenue per case.
Alphatec’s Grand Slam Second Quarter

Alphatec, under the leadership of Mr. Patrick Miles, was the #1 market share gainer during COVID ravished 2020, then again in 2021 and now, almost certainly, will be the #1 market share gainer for 2023. Globus Medical took the crown away from Alphatec in 2022, but Alphatec has snatched it back.
Here are the numbers:
- Q2 Sales: $117 million. That’s 39% higher than last year’s second quarter—and well above the forecasts from Wall Street’s analyst corps, who, it’s worth mentioning, are truly enamored with the company.
- Q2 Surgical Sales Growth: 41% to $102 million.
- Q2 Gross Profit: 73.2%, up 340 basis points from last year’s 69.5%.
- Earnings Before Interest, Taxes and Amortization (non-cash) Expenses: $1.5 million up dramatically from the Street’s consensus of a $(1.8) million loss.
But wait, there’s still more. Here’s what one of the top Wall Street analysts, David Saxon CFA with Needham and Company LLC, wrote to institutional investors: “We believe there could still be more upside given conservative procedure volume growth assumptions. We also believe upside on the top-line could allow ATEC to see a faster profitability ramp. Given these points, we reiterate our Buy rating and raise our price target to $20 from $19.”
Wall Street’s analysts are updating their models and consensus for the full year seems to be coalescing around $460 million for the full year and then $545 million for 2024.
What is the secret behind Alphatec’s performance? Three reasons, I think:
- Focus on surgeon training – 150 surgeons were trained in the second quarter alone;
- An obsession on material improvements in spine surgery – Miles and his team are very good at avoiding distractions. They have one job and one job only. “ATEC’s 100% spine focus gives us a unique ability to create comprehensive, ground-up procedures that directly improve spine care,” said Miles;
- Advanced, but integrated, imaging and other digital tools – EOS and navigation-enabled robotics. In short, Alphatec is among a handful of spine companies who are leading surgeons from an artisanal practice to the modern approach of integrating engineered processes.

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.